Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,005 | 7,307 | 8,524 | 9,333 | 13,758 |
| Receivables | 1,994 | 1,261 | 1,605 | 2,783 | 1,859 |
| Inventories | 1,099 | 1,307 | 1,759 | 1,821 | 2,455 |
| Other current assets | 36 | 37 | 286 | 0 | 0 |
| TOTAL | $9,393 | $11,500 | $13,835 | $16,503 | $20,354 |
| Non-Current Assets | |||||
| PPE Net | 9,244 | 9,806 | 9,892 | 10,923 | 10,659 |
| Investments And Advances | 131 | 0 | 0 | 0 | 0 |
| Intangibles | 2 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 71 | 125 | 132 | 132 | 128 |
| TOTAL | $9,448 | $9,931 | $10,024 | $11,055 | $10,787 |
| Total Assets | $18,841 | $21,431 | $23,859 | $27,558 | $31,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 926 | 1,883 | 1,948 | 3,056 | 4,711 |
| Other current liabilities | 569 | 1,393 | 1,686 | 2,130 | 1,864 |
| TOTAL | $1,685 | $3,613 | $3,983 | $5,532 | $7,059 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 19 | 19 | 122 |
| Other Non-Current Liabilities | 1,837 | 12,918 | 13,766 | 13,901 | 13,008 |
| TOTAL | $1,837 | $13,976 | $14,796 | $14,929 | $13,938 |
| Total Liabilities | $3,522 | $17,589 | $18,779 | $20,461 | $20,997 |
| Shareholders' Equity | |||||
| Common Shares | 22,625 | 22,624 | 22,622 | 22,600 | 22,503 |
| Retained earnings | -9,751 | -20,508 | -19,048 | -17,227 | -14,655 |
| Other shareholders' equity | -1,726 | -2,444 | -2,662 | -2,466 | -1,979 |
| TOTAL | $15,319 | $3,842 | $5,080 | $7,097 | $10,144 |
| Total Liabilities And Equity | $18,841 | $21,431 | $23,859 | $27,558 | $31,141 |